Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Cefazolin Versus Anti-Staphylococcal Penicillins for the Treatment of Patients with Methicillin-Susceptible Staphylococcus aureus Infection: A Meta-Analysis with Trial Sequential Analysis.

Allen JM, Bakare L, Casapao AM, Klinker K, Childs-Kean LM, Pomputius AF.

Infect Dis Ther. 2019 Aug 8. doi: 10.1007/s40121-019-00259-4. [Epub ahead of print]

PMID:
31392580
2.

Pet Nemo's Pills - The Last Loophole in Antimicrobial Stewardship?

Egelund EF, Casapao AM.

Clin Infect Dis. 2019 May 10. pii: ciz388. doi: 10.1093/cid/ciz388. [Epub ahead of print] No abstract available.

PMID:
31074491
3.

Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus.

Claeys KC, Zasowski EJ, Trinh TD, Casapao AM, Pogue JM, Bhatia N, Mynatt RP, Wilson SS, Arthur C, Welch R, Sherwin R, Hafeez W, Levine DP, Kaye KS, Delgado G, Giuliano CA, Takla R, Rieck C, Johnson LB, Murray KP, Gordon J, Reyes K, Hartman P, Davis SL, Rybak MJ.

Infect Dis Ther. 2019 Jun;8(2):199-208. doi: 10.1007/s40121-019-0242-5. Epub 2019 Mar 27.

4.

Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: Does β-Lactam Class Matter?

Dilworth TJ, Casapao AM, Ibrahim OM, Jacobs DM, Bowers DR, Beyda ND, Mercier RC.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02211-18. doi: 10.1128/AAC.02211-18. Print 2019 Mar.

5.

Role of Vancomycin Minimum Inhibitory Concentrations by Modified Population Analysis Profile Method and Clinical Outcomes in High Inoculum Methicillin-Resistant Staphylococcus aureus Infections.

Trinh TD, Zasowski EJ, Claeys KC, Casapao AM, Compton M, Lagnf A, Kidambi SD, Levine DP, Rybak MJ.

Infect Dis Ther. 2018 Mar;7(1):161-169. doi: 10.1007/s40121-018-0187-0. Epub 2018 Feb 22.

6.

Overtreatment of Asymptomatic Candiduria among Hospitalized Patients: a Multi-institutional Study.

Jacobs DM, Dilworth TJ, Beyda ND, Casapao AM, Bowers DR.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01464-17. doi: 10.1128/AAC.01464-17. Print 2018 Jan.

7.

Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.

Casapao AM, Jacobs DM, Bowers DR, Beyda ND, Dilworth TJ; REACH-ID Study Group.

Pharmacotherapy. 2017 Nov;37(11):1347-1356. doi: 10.1002/phar.2034. Epub 2017 Nov 2.

PMID:
28949410
8.

Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Zasowski EJ, Trinh TD, Claeys KC, Casapao AM, Sabagha N, Lagnf AM, Klinker KP, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02015-16. doi: 10.1128/AAC.02015-16. Print 2017 Feb.

9.

Clinical pathway for moderate to severe acute bacterial skin and skin structure infections from a US perspective: a roundtable discussion.

Bosso JA, Casapao AM, Edwards J, Klinker K, McCoy C, Nicolau DP, Perez KK, Marcarelli A, Dua D.

Hosp Pract (1995). 2016 Oct;44(4):183-189. Epub 2016 Sep 12.

PMID:
27598313
10.

Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Claeys KC, Zasowski EJ, Casapao AM, Lagnf AM, Nagel JL, Nguyen CT, Hallesy JA, Compton MT, Kaye KS, Levine DP, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5841-8. doi: 10.1128/AAC.00227-16. Print 2016 Oct.

11.

Comparison of clinical outcomes and risk factors in polymicrobial versus monomicrobial enterococcal bloodstream infections.

Lagnf AM, Zasowski EJ, Claeys KC, Casapao AM, Rybak MJ.

Am J Infect Control. 2016 Aug 1;44(8):917-21. doi: 10.1016/j.ajic.2016.02.017. Epub 2016 Apr 11.

PMID:
27079241
12.

Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditis.

Casapao AM, Lodise TP, Davis SL, Claeys KC, Kullar R, Levine DP, Rybak MJ.

Antimicrob Agents Chemother. 2015;59(6):2978-85. doi: 10.1128/AAC.03970-14. Epub 2015 Mar 9.

13.

Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.

Claeys KC, Smith JR, Casapao AM, Mynatt RP, Avery L, Shroff A, Yamamura D, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2015 Apr;59(4):1969-76. doi: 10.1128/AAC.04141-14. Epub 2015 Jan 20.

14.

Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.

Sakoulas G, Moise PA, Casapao AM, Nonejuie P, Olson J, Okumura CY, Rybak MJ, Kullar R, Dhand A, Rose WE, Goff DA, Bressler AM, Lee Y, Pogliano J, Johns S, Kaatz GW, Ebright JR, Nizet V.

Clin Ther. 2014 Oct 1;36(10):1317-33. doi: 10.1016/j.clinthera.2014.05.061. Epub 2014 Jul 10.

PMID:
25017183
15.

Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus.

Casapao AM, Davis SL, McRoberts JP, Lagnf AM, Patel S, Kullar R, Levine DP, Rybak MJ.

Antimicrob Agents Chemother. 2014 Aug;58(8):4636-41. doi: 10.1128/AAC.02820-13. Epub 2014 Jun 2.

16.

Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy.

Casapao AM, Davis SL, Barr VO, Klinker KP, Goff DA, Barber KE, Kaye KS, Mynatt RP, Molloy LM, Pogue JM, Rybak MJ.

Antimicrob Agents Chemother. 2014 May;58(5):2541-6. doi: 10.1128/AAC.02371-13. Epub 2014 Feb 18.

17.

A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis.

Kullar R, Casapao AM, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ.

J Antimicrob Chemother. 2013 Dec;68(12):2921-6. doi: 10.1093/jac/dkt294. Epub 2013 Aug 8.

18.

Clinical Outcomes in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bloodstream Infection.

Casapao AM, Leonard SN, Davis SL, Lodise TP, Patel N, Goff DA, LaPlante KL, Potoski BA, Rybak MJ.

Antimicrob Agents Chemother. 2013 Sep;57(9):4252-4259. doi: 10.1128/AAC.00380-13. Epub 2013 Jun 24.

19.

Multicenter study of high-dose daptomycin for treatment of enterococcal infections.

Casapao AM, Kullar R, Davis SL, Levine DP, Zhao JJ, Potoski BA, Goff DA, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ.

Antimicrob Agents Chemother. 2013 Sep;57(9):4190-6. doi: 10.1128/AAC.00526-13. Epub 2013 Jun 17.

20.

Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection.

Casapao AM, Steed ME, Levine DP, Rybak MJ.

Expert Opin Pharmacother. 2012 Jun;13(8):1177-86. doi: 10.1517/14656566.2012.685718. Review.

PMID:
22594846

Supplemental Content

Loading ...
Support Center